Abstract
The objective of this study is to perform a meta-analysis of all randomized controlled trials (RCTs) that surveyed the efficacy and safety of preoperative misoprostol versus placebo during abdominal hysterectomy. Six databases were screened from inception until 3 August 2022. The eligible studies were assessed for risk of bias. The outcomes were summarized as mean difference (MD) and risk ratio (RR) with 95% confidence intervals (CI) in a random-effects model. Ten RCTs with 1076 patients (misoprostol = 537, placebo = 539 patients) were analyzed. Six and four RCTs had an overall low and high risk of bias (single-blinded), respectively. The mean intraoperative blood loss (n = 10 RCTs, MD = − 78.97 ml, 95% [− 130.89, − 27.06], p = 0.003), mean difference in hemoglobin drop (n = 10 RCTs, MD = − 0.42 g/dl, 95% CI [− 0.69, − 0.14], p = 0.003), and mean length of hospital stay (n = 5 RCTs, MD = − 0.2 d, 95% CI [− 0.24, − 0.16], p < 0.001) were significantly reduced in favor of the misoprostol group compared with the placebo group. However, there were no significant differences between both groups regarding the mean operative time (n = 8 RCTs, MD = − 0.63 min, 95% CI [− 5.07, 3.81], p = 0.78), rate of perioperative blood transfusion (n = 7 RCTs, RR = 0.83, 95% CI [0.53, 1.3], p = 0.42), and rate of drug-related adverse events (i.e., nausea, vomiting, diarrhea, headache, chills, and fever). Leave-one-out sensitivity analyses revealed stability for all endpoints, except hospitalization stay. There was no publication bias for all endpoints, except perioperative blood transfusion. Among patients undergoing abdominal hysterectomy, preoperative administration of misoprostol was largely safe and linked to substantial decrease in blood loss-related morbidities.
Similar content being viewed by others
Data Availability
All data are available within the manuscript and its supplemental files.
Code Availability
Review Manager Software version 5.4.0. for Windows.
References
Bachmann GA. Hysterectomy. A critical review. J Reprod Med. 1990;35(9):839–62.
Johnson N, Barlow D, Lethaby A, Tavender E, Curr L, Garry R. Methods of hysterectomy: systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;330(7506):1478.
Hill DJ. Complications of hysterectomy. Baillieres Clin Obstet Gynaecol. 1997;11(1):181–97.
Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013;121(3):654–73.
Ramdhan RC, Loukas M, Tubbs RS. Anatomical complications of hysterectomy: a review. Clin Anat. 2017;30(7):946–52.
Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99(Suppl 2):S160–7.
Choksuchat C. Clinical use of misoprostol in nonpregnant women: review article. J Minim Invasive Gynecol. 2010;17(4):449–55.
Chai J, Hon E, Li CF, Pun TC, Yeung SB, Ho PC. A pilot study of pre-operative misoprostol in reducing operative blood loss during hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2011;158(1):72–5.
Panichpongpan A, Satirapod C, Likittanasombat P, Ayuttaya NIN. Preoperative sublingual misoprostol in reducing intraoperative blood loss during abdominal hysterectomy. Thai J Obstet Gynaecol 2014:187–93.
Biswas J, Chaudhuri P, Mandal A, Bandyopadhyay SN, Dasgupta S, Pal A. Effect of a single preoperative dose of sublingual misoprostol on intraoperative blood loss during total abdominal hysterectomy. Int J Gynaecol Obstet. 2013;122(3):244–7.
Tabatabai A, Karimi-Zarchi M, Meibodi B, Vaghefi M, Yazdian P, Zeidabadi M, et al. Effects of a single rectal dose of Misoprostol prior to abdominal hysterectomy in women with symptomatic leiomyoma: a randomized double blind clinical trial. Electron Physician. 2015;7(6):1372.
Nankali A, Fakheri T, Hematti M, Noori T. Pre-operative sublingual misoprostol and intra-operative blood loss during total abdominal hysterectomy: a randomized single-blinded controlled clinical trial. Middle East J Fam Med. 2017;7(10):35.
Makled A, Alsaied A, Ismail O, Farhan S. Effect of sublingual misoprostol on intraoperative blood loss during abdominal hysterectomy: randomized controlled trial. Egypt J Hosp Med. 2017;69(1):1692–7.
Anant M, Agarwal A, Sinha K, Raj N. Single-dose preoperative vaginal misoprostol for reducing blood loss during abdominal hysterectomy: a randomized study. J Gynecol Surg. 2021;37(5):424–9.
Harinsalai T, Meckjarusnapa M, Rattanakosol J, Sripipattanakul M, Tangsiriwatthana T. The effectiveness of sublingual misoprostol in reducing operative blood loss during total abdominal hysterectomy: a randomized controlled trial. Thai J Obstet Gynaecol 2019:210–5.
Parashi S, Astaraei V, Vahdat M, Dini P, Mohammadianamiri M. The Effect of a Single Preoperative dose of sublingual misoprostol in reducing intraoperative blood loss after total abdominal hysterectomy: a single-blind randomized controlled trial. J Obstet, Gynecol Cancer Res (JOGCR). 2018;3(4):143–7.
Aziz AEA, Sokary AASE, Borg HMES, Marey SK. Effect of preoperative single dose misoprostol on intraoperative blood loss during abdominal hysterectomy: a randomized controlled trial. J Adv Med Med Res. 2022;34(1):127–34.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.
Higgins J GS, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 [Internet]. [updated March 2011]. The Cochrane Collaboration, www.handbook.cochrane.org AAf.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev. 1992;14:154–76.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Thompson JD, Birch HW. Indications of hysterectomy. Clin Obstet Gynecol. 1981;24(4):1245–58.
Discepola F, Valenti DA, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol. 2007;110(6):1301–3.
Chen CL, Xu YJ, Liu P, Zhu JH, Ma B, Zeng BL, et al. Characteristics of vascular supply to uterine leiomyoma: an analysis of digital subtraction angiography imaging in 518 cases. Eur Radiol. 2013;23(3):774–9.
Maged AM, Wali AA, Metwally AA, Salah N. The efficacy of misoprostol in reducing intraoperative blood loss in women undergoing elective cesarean section. A systematic review and meta-analysis. J Obstet Gynaecol Res. 2022;48(8):2038–70.
Wali S, Balfoussia D, Touqmatchi D, Quinn S. Misoprostol for open myomectomy: a systematic review and meta-analysis of randomised control trials. BJOG. 2021;128(3):476–83.
Murji A, Lam M, Allen B, Richard L, Shariff SZ, Austin PC, et al. Risks of preoperative anemia in women undergoing elective hysterectomy and myomectomy. Am J Obstet Gynecol. 2019;221(6):629.e1-e18.
Rock WA Jr, Meeks GR. Managing anemia and blood loss in elective gynecologic surgery patients. J Reprod Med. 2001;46(5 Suppl):507–14.
Abu-Zaid A, Baradwan S, Badghish E, AlSghan R, Ghazi A, Albouq B, et al. Prophylactic tranexamic acid to reduce blood loss and related morbidities during hysterectomy: a systematic review and meta-analysis of randomized controlled trials. Obstet Gynecol Sci. 2022;65(5):406–19.
Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet. 2013;121(2):186–9.
Gingold JA, Chichura A, Harnegie MP, Kho RM. Perioperative interventions to minimize blood loss at the time of hysterectomy for uterine leiomyomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2019;26(7):1234-52.e1.
Park H, Yoon BS, Seong SJ, Kim JY, Shim JY, Park CT. Can misoprostol reduce blood loss in laparoscopy-assisted vaginal hysterectomy? Aust N Z J Obstet Gynaecol. 2011;51(3):248–51.
Hafidh B, Latifah HM, Gari A, Alshahrani MS, AlSghan R, Alkhamis WH, et al. Vasopressin to control blood loss during hysterectomy: a systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol 2021.
Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG. 2002;109(10):1097–108.
Author information
Authors and Affiliations
Contributions
AA contributed to study conception, data analysis, study supervision, and manuscript writing. YAM, SB, RS, EF, ERM, SMM, and ASA contributed to literature review, data collection, data interpretation, and revision of manuscript for editorial and intellectual contents. All authors read and approved the final draft of manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Not required as this research does not involve direct patient or animal contact.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
IRB Approval
Not applicable. IRB approval is not needed as this research (systematic review and meta-analysis) does not involve direct patient or animal contact.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abu-Zaid, A., Mohammed, Y.A., Baradwan, S. et al. Preoperative Misoprostol to Reduce Blood Loss and Related Morbidities During Abdominal Hysterectomy: a Systematic Review and Meta-analysis of 10 Randomized Placebo-Controlled Trials. Reprod. Sci. 30, 1470–1481 (2023). https://doi.org/10.1007/s43032-022-01121-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-022-01121-8